产品名称
MILLIPLEX® 人肾损伤磁珠板1 - 毒性多重检测,
Quality Level
description
Configurable Human Kidney Toxicity 8-plex Panel 1
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
technique(s)
multiplexing: suitable
input
urine
assay range
accuracy: 73-117%, sensitivity: 0.010-6.473 ng/mL
(MinDC = 2SD), standard curve range: 0.005-5 ng/mL
(IP-10), standard curve range: 0.02-25 ng/mL
(Renin), standard curve range: 0.05-50 ng/mL
(GSTα), standard curve range: 0.05-50 ng/mL
(KIM-1), standard curve range: 0.10-100 ng/mL
(TIMP-1), standard curve range: 0.20-200 ng/mL
(Calbindin), standard curve range: 0.34-350 ng/mL
(Collagen IV), standard curve range: 0.49-500 ng/mL
(TFF-3), standard curve range: 5.86-6,000 ng/mL
(FABP1), inter-assay cv: <15%
intra-assay cv: <10%
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: Calbindin, Collagen IV, GSTα, IP-10, KIM-1, Renin, TFF-3, TIMP-1
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Includes 8 key biomarkers associated with kidney injury and renal function
- Targets proteins involved in inflammation, tubular damage, fibrosis, and renal stress
- Designed for use with human serum, plasma, or urine samples
- Compatible with Luminex® xMAP® technology for multiplex analysis
- Validated for high sensitivity, specificity, and reproducibility
- Enables early detection and monitoring of kidney injury and dysfunction
- Supports research in nephrotoxicity, acute kidney injury (AKI), chronic kidney disease (CKD), and drug safety
- Reduces sample volume requirements while increasing data throughput
- Improves efficiency in biomarker discovery and translational nephrology research
- Facilitates high-throughput screening with consistent and reliable result
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
Still not finding the right product?
Explore all of our products under MILLIPLEX® 人肾损伤磁珠板1 - 毒性多重检测
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
法规信息
此项目有
相关内容
Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.
Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.
Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.